Zealand Pharma A/S (CPH:ZEAL)
420.00
-5.90 (-1.39%)
May 13, 2025, 4:01 PM CET
Zealand Pharma Revenue
Zealand Pharma had revenue of 8.09M DKK in the quarter ending March 31, 2025, a decrease of -46.37%. This brings the company's revenue in the last twelve months to 55.69M, down -83.82% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.
Revenue (ttm)
55.69M
Revenue Growth
-83.82%
P/S Ratio
540.61
Revenue / Employee
144.66K
Employees
335
Market Cap
30.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69M | -280.10M | -81.71% |
Dec 31, 2023 | 342.79M | 238.80M | 229.65% |
Dec 31, 2022 | 103.99M | -4.56M | -4.20% |
Dec 31, 2021 | 108.55M | -83.46M | -43.47% |
Dec 31, 2020 | 192.00M | 150.67M | 364.52% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Nordisk | 303.14B |
Coloplast | 27.79B |
Genmab | 21.64B |
Demant | 22.42B |
ALK-Abelló | 5.71B |
H. Lundbeck | 22.00B |
Ambu A/S | 5.83B |
GN Store Nord | 17.67B |
Zealand Pharma News
- 1 day ago - Zealand Pharma to participate in upcoming healthcare investor conferences in May and June 2025 - GlobeNewsWire
- 3 days ago - Zealand Pharma A/S (ZLDPF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Zealand Pharma announces closing of collaboration and license agreement with Roche - GlobeNewsWire
- 4 days ago - Zealand Pharma A/S 2025 Q1 - Results - Earnings Call Presentation - Seeking Alpha
- 5 days ago - Zealand Pharma Announces Financial Results for the First Three Months of 2025 - GlobeNewsWire
- 11 days ago - Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit - CNBC
- 11 days ago - Zealand Pharma conference call on May 8 at 2pm CET (8am ET) to present first quarter 2025 financial results - GlobeNewsWire
- 16 days ago - Zealand Pharma says obesity drug deal with Roche will help it stay independent - Financial Times